Arkansas Legal Resource Navigator

42 U.S.C. § 282d — Transferred

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 282d — Transferred

### Statutory Notes #### Codification Section, act July 1, 1944, ch. 373, title IV, § 402C, as added Pub. L. 111–148, title X, § 10409(d), Mar. 23, 2010, 124 Stat. 978, which related to the Cures Acceleration Network, was renumbered section 480 of act July 1, 1944, by Pub. L. 112–74, div. F, title II, § 221(c)(1)(A), Dec. 23, 2011, 125 Stat. 1089, and transferred to [section 287a of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section287a&num=0&edition=prelim).

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 282d

Stored review status: release_metadata_unconfirmed. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: ce32d65f56c24e31fca90eb7859cbf3d0ea52b248855d3c608683bff53d403d4. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:record_usc_c526d164c53c90870347421c
Source file: Laws/federal/codes/united-states-code/title-42/section-282d-transferred--87f5cfc329.md
Pages: Not recorded – Not recorded
Passage SHA-256: fa0d5b865aef1a21908153ce4f18dc65f183e892a180425e592ee91c9987081f

Source location: Title 42, Chapter 6A, § 282d; chapter-6a-public-health-service.md

Stored source content

### Statutory Notes #### Codification Section, act July 1, 1944, ch. 373, title IV, § 402C, as added Pub. L. 111–148, title X, § 10409(d), Mar. 23, 2010, 124 Stat. 978, which related to the Cures Acceleration Network, was renumbered section 480 of act July 1, 1944, by Pub. L. 112–74, div. F, title II, § 221(c)(1)(A), Dec. 23, 2011, 125 Stat. 1089, and transferred to [section 287a of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section287a&num=0&edition=prelim).

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 287a — Cures Acceleration Network

**(a) Definitions** In this section: (1) **Biological product** — The term “biological product” has the meaning given such term in [section 262 of this title](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title42-section262&num=0&edition=prelim). (2) **Drug; device** — The terms “drug” and “device” have the meanings given such terms in [section 321 of title 21](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section321&num=0&edition=prelim). (3) **High need cure** — The term “high need cure” means a drug (as that term is defined by [section 321(g)(1) of title 21](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section321/g/1&num=0&edition=prelim),11 So in original. A closing parenthesis probably should precede the comma. biological product (as that term is defined by section 262(i) 22 See References in Text note below. of this title), or device (as that term is defined by [section 321(h) of title 21](https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section321/h&num=0&edition=prelim)) that, in the determination of the Director of the Center— (A) is a priority to diagnose, mitigate, prevent, or treat harm from any disease or condition; and (B) for which the incentives of the commercial market are unlikely to result in its adequate or timely development. (4) **Medical product** — The term “medical product” means a drug, device, biological product, or product that is a combination of drugs, devices, and biological products. **(b) Establishment of the Cures Acceleration Network** Subject to the appropriation of funds as described in subsection (g), there is established within the Center a program to be known as the Cures Acceleration Network (referred to in this section as “CAN”), which s

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 287a

Stored review status: release_metadata_unconfirmed. Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 202 — Definitions

When used in this chapter— **(a)** The term “Service” means the Public Health Service; **(b)** The term “Surgeon General” means the Surgeon General of the Public Health Service; **(c)** Unless the context otherwise requires, the term “Secretary” means the Secretary of Health and Human Services. **(d)** The term “regulations”, except when otherwise specified, means rules and regulations made by the Surgeon General with the approval of the Secretary; **(e)** The term “executive department” means any executive department, agency, or independent establishment of the United States or any corporation wholly owned by the United States; **(f)** Except as provided in sections 246(g)(4)(B),11 See References in Text note below. 247c(c)(1),1 254d(h)(3),1 263c(5),1 264(d), 292a(9),1 300a(c), 300f(13), and 300n(1) 1 of this title, the term “State” includes, in addition to the several States, only the District of Columbia, Guam, the Commonwealth of Puerto Rico, the Northern Mariana Islands, the Virgin Islands, American Samoa, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. **(g)** The term “possession” includes, among other possessions, Puerto Rico and the Virgin Islands; **(h)** Repealed. Pub. L. 97–35, title IX, § 986(a), Aug. 13, 1981, 95 Stat. 603. **(i)** The term “vessel” includes every description of watercraft or other artificial contrivance used, or capable of being used, as a means of transportation on water, exclusive of aircraft and amphibious contrivances; **(j)** The term “habit-forming narcotic drug” or “narcotic” means opium and coca leaves and the several alkaloids derived therefrom, the best known of these alkaloids being morphia, heroin, and codeine, obtained from opium, and cocaine derived from the coca

Source: Supplied U.S. Code snapshot — release unconfirmed · 42 U.S.C. § 202

Stored review status: release_metadata_unconfirmed. Incoming connection: Explicit cross-reference supplied in source Markdown; currentness and applicability require review.

Federal law — U.S. Code and appendices · legal_authorities

42 U.S.C. § 282d — Transferred

Page 652 TITLE 42—THE PUBLIC HEALTH AND WELFARE § 282b scribed in section 402(b)(7)(B)(ii) of the Public Health Service Act [42 U.S.C. 282(b)(7)(B)(ii)], as added by subsection (a).’’ § 282b. Electronic coding of grants and activities The Secretary, acting through the Director of NIH, shall establish an electronic system to uni- formly code research grants and activities of the Office of the Director and of all the national re- search institutes and national centers. The elec- tronic system shall be searchable by a variety of codes, such as the type of research grant, the re- search entity managing the grant, and the pub- lic health area of interest. When permissible, the Secretary, acting through the Director of NIH, shall provide information on relevant lit- erature and patents that are associated with re- search activities of the National Institutes of Health. (July 1, 1944, ch. 373, title IV, § 402B, as added Pub. L. 109–482, title I, § 104(a)(3), Jan. 15, 2007, 120 Stat. 3689.) Statutory Notes and Related Subsidiaries EFFECTIVE DATE Section applicable only with respect to amounts ap- propriated for fiscal year 2007 or subsequent fiscal years, see section 109 of Pub. L. 109–482, set out as an Effective Date of 2007 Amendment note under section 281 of this title. § 282c. Public access to funded investigators’ final manuscripts The Director of the National Institutes of Health (‘‘NIH’’) shall require in the current fis- cal year and thereafter that all investigators funded by the NIH submit or have submitted for them to the National Library of Medicine’s PubMed Central an electronic version of their final, peer-reviewed manuscripts upon accept- ance for publication, to be made publicly avail- able no later than 12 months after the official d

Source: Supplied 2024 U.S. Code historical extraction · 42 U.S.C. § 282d

Stored review status: historical_2024_not_currentness_verified. Same stored citation; legal effect and authority still require review.